Cargando…
Low Doses of Celecoxib Attenuate Gut Barrier Failure During Experimental Peritonitis
The intestinal barrier becomes compromised during systemic inflammation, leading to entry of luminal bacteria into the host and gut origin sepsis. Pathogenesis and treatment of inflammatory gut barrier failure is an important problem in critical care. In this study we examined the role of cyclooxyge...
Autores principales: | Short, Scott S., Wang, Jin, Castle, Shannon L., Fernandez, G. Esteban, Smiley, Nancy, Zobel, Michael, Pontarelli, Elizabeth M., Papillon, Stephanie C., Grishin, Anatoly V., Ford, Henri R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966546/ https://www.ncbi.nlm.nih.gov/pubmed/24126890 http://dx.doi.org/10.1038/labinvest.2013.119 |
Ejemplares similares
-
The role of the intestinal microbiota in the pathogenesis of necrotizing enterocolitis
por: Grishin, Anatoly, et al.
Publicado: (2013) -
Cytokinesis-block micronucleus assay of celecoxib and celecoxib derivatives
por: Reimann, Hauke, et al.
Publicado: (2020) -
Celecoxib Does Not Attenuate the Antiplatelet Effects of Aspirin and Clopidogrel in Healthy Volunteers
por: Lee, Wonjae, et al.
Publicado: (2010) -
Colonization with Escherichia coli EC 25 protects neonatal rats from necrotizing enterocolitis
por: Thomas, Debi M., et al.
Publicado: (2017) -
Cyclooxygenase-2 inhibitor celecoxib attenuates joint contracture following immobilization in rat knees
por: Ozawa, Junya, et al.
Publicado: (2016)